.png)
Delano Seiveright, Minister of State in the Ministry of Industry, Investment & Commerce, says the Jamaican government is closely monitoring developments in the United States, in what he says could be one of the biggest shifts in that country's drug policy in decades.
It was reported on Friday day that U.S. President Donald Trump is considering reclassifying marijuana from a Schedule I drug to Schedule III, placing it in the same category as mild painkillers and other substances with accepted medical use
Mr Seiveright says the change in the designation of ganja would open significant opportunities for Jamaica.
According to Mr Seiveright, the move would immediately de-risk the cannabis industry for financial institutions.
Cannabis stakeholders in Jamaica have welcomed the reports that an executive order could be signed by President Trump as early as Monday to authorize the reclassification.
Major boost
Andray McKenzie, Chief Operating Officer of Medicanja Limited, in response to this development, said the reclassification of ganja in the United States would be a major boost for Jamaican farmers who were adversely affected by Hurricane Melissa.
He says there’s a sufficient supply of ganja products in Jamaica to meet demand.
The legal framework for ganja use in Jamaica applies specifically to medical, therapeutic, scientific and Rastafari religious purposes.
All feeds
